Identification of a new centrosomal protein interacting with the Polo-like kinase

被引:0
|
作者
Guarguaglini, G
Duncan, PI
Stierhof, YD
Nigg, EA
机构
[1] Max Planck Inst Biochem, Dept Cell Biol, D-82152 Martinsried, Germany
[2] Univ Tubingen, Ctr Mol Biol Plants, D-72076 Tubingen, Germany
来源
CELL MOTILITY AND THE CYTOSKELETON | 2003年 / 54卷 / 02期
关键词
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
64
引用
收藏
页码:177 / 177
页数:1
相关论文
共 50 条
  • [21] The balance of Polo-like kinase 1 in tumorigenesis
    Lu, Lin-Yu
    Yu, Xiaochun
    CELL DIVISION, 2009, 4
  • [22] Developing polo-like kinase 1 inhibitors
    Huang, Xufeng
    Xie, Zhouling
    Liao, Chenzhong
    FUTURE MEDICINAL CHEMISTRY, 2020, 12 (10) : 869 - 871
  • [23] Human Polo-like Kinase Inhibitors as Antiplasmodials
    Bohmer, Monica J.
    Wang, Jinhua
    Istvan, Eva S.
    Luth, Madeline R.
    Collins, Jennifer E.
    Huttlin, Edward L.
    Wang, Lushun
    Mittal, Nimisha
    Hao, Mingfeng
    Kwiatkowski, Nicholas P.
    Gygi, Steven P.
    Chakrabarti, Ratna
    Deng, Xianming
    Goldberg, Daniel E.
    Winzeler, Elizabeth A.
    Gray, Nathanael S.
    Chakrabarti, Debopam
    ACS INFECTIOUS DISEASES, 2023, 9 (04): : 1004 - 1021
  • [24] Polo-like Kinase 4 Shapes Up
    Levine, Michelle S.
    Holland, Andrew J.
    STRUCTURE, 2014, 22 (08) : 1071 - 1073
  • [25] Polo-like kinase inhibitors in hematologic malignancies
    Talati, Chetasi
    Griffiths, Elizabeth A.
    Wetzler, Meir
    Wang, Eunice S.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2016, 98 : 200 - 210
  • [26] Regulation of cytokinesis by polo-like kinase 4
    Press, Michael F.
    Xie, Bin
    Davenport, Simon
    Zhou, Yu
    O'Brien, Neil
    Palazzolo, Michael
    Mak, Tak
    Brugge, Joan
    Slamon, Dennis J.
    CANCER RESEARCH, 2016, 76
  • [27] Progress in the discovery of polo-like kinase inhibitors
    McInnes, C
    Mezna, M
    Fischer, PM
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2005, 5 (02) : 181 - 197
  • [28] Identification of Novel Polo-like Kinase 1 Inhibitors by a Hybrid Virtual Screening
    Lu, Shuai
    Sun, Shan-Liang
    Liu, Hai-Chun
    Chen, Ya-Dong
    Yuan, Hao-Liang
    Gao, Yi-Ping
    Yang, Pei
    Lu, Tao
    CHEMICAL BIOLOGY & DRUG DESIGN, 2012, 80 (02) : 328 - 339
  • [29] Polo-like kinase 1, a new therapeutic target in hepatocellular carcinoma
    Mok, Wei Chuen
    Wasser, Shanthi
    Tan, Theresa
    Lim, Seng Gee
    WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (27) : 3527 - 3536
  • [30] Epigenetic inactivation implies a tumor suppressor function in hematologic malignancies for Polo-like kinase 2 but not Polo-like kinase 3
    Smith, Paul
    Syed, Nelofer
    Crook, Tim
    CELL CYCLE, 2006, 5 (12) : 1262 - 1264